Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Lifeward Ltd. (LFWD : NSDQ)

• Company Description    Lifeward designs, develops and commercializes life-changing solutions which span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. The company's portfolio features products including the ReWalk Exoskeleton, the AlterG Anti-Gravity system, the MyoCycle FES System, and the ReStore Exo-Suit. Lifeward, formerly known as ReWalk Robotics Ltd., is based in MARLBOROUGH, Mass. Number of Employees: 81

• Price / Volume Information    Yesterday's Closing Price: $5.85 Daily Weekly Monthly 20 Day Moving Average: 4,563 shares Shares Outstanding: 2.83 (millions) Market Capitalization: $16.57 (millions) Beta: 0.47 52 Week High: $10.20 52 Week Low: $4.14 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -16.19% -16.23% 12 Week -30.23% -31.56% Year To Date -15.49% -25.09%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2 Cabot Rd - Hudson,MA 01749 USA ph: 508-251-1154 fax: - ir@golifeward.com https://golifeward.com

• General Corporate Information    Officers Mark Grant - Chief Executive Officer;President and Director Robert Marshall - Chairman of the Board Almog Adar - Chief Financial Officer Randel Richner - Director Michael Swinford - Director Peer Information Lifeward Ltd. (CHCR) Lifeward Ltd. (ESRX) Lifeward Ltd. (MYDP) Lifeward Ltd. (COR) Lifeward Ltd. (GBCS) Lifeward Ltd. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: M8216Q309 SIC: 3842 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/13/26 Share - Related Items Shares Outstanding: 2.83 Most Recent Split Date: 2.00 (0.08:1) Beta: 0.47 Market Capitalization: $16.57 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.57 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.44 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.35 Price/Cash Flow: - Price / Sales: 0.76 EPS Growth vs. Year Ago Period: 79.03% vs. Previous Quarter: 78.21% Sales Growth vs. Year Ago Period: 15.71% vs. Previous Quarter: 68.82% ROE 09/30/26 - - 06/30/26 - -235.86 03/31/26 - -243.14 ROA 09/30/26 - - 06/30/26 - -81.72 03/31/26 - -97.39 Current Ratio 09/30/26 - - 06/30/26 - 2.33 03/31/26 - 2.40 Quick Ratio 09/30/26 - - 06/30/26 - 1.77 03/31/26 - 1.82 Operating Margin 09/30/26 - - 06/30/26 - -107.19 03/31/26 - -123.66 Net Margin 09/30/26 - - 06/30/26 - -141.28 03/31/26 - -123.66 Pre-Tax Margin 09/30/26 - - 06/30/26 - -141.51 03/31/26 - -123.94 Book Value 09/30/26 - - 06/30/26 - 4.34 03/31/26 - 2.26 Inventory Turnover 09/30/26 - - 06/30/26 - 2.21 03/31/26 - 1.99 Debt-to-Equity 09/30/26 - - 06/30/26 - 0.70 03/31/26 - 1.16 Debt-to-Capital 09/30/26 - - 06/30/26 - 41.07 03/31/26 - 53.63

Powered by Zacks Investment Research ©